-
1
المؤلفون: Andrew Ustianowski, Nikos Kotsopoulos, Mark P. Connolly
المصدر: Journal of Medical Economics, 21(1), 19-26. Taylor & Francis Ltd
مصطلحات موضوعية: Complementary Therapies, Male, economic evaluation, ledipasvir, IMPACT, Cost-Benefit Analysis, Severity of Illness Index, Cohort Studies, Indirect costs, Tax revenue, 0302 clinical medicine, Cost of Illness, Health care, 030212 general & internal medicine, Prospective Studies, PERSPECTIVE, health care economics and organizations, Cost–benefit analysis, Public economics, Health Policy, Societal impact of nanotechnology, Hepatitis C, Health Care Costs, societal impact, Middle Aged, WORK PRODUCTIVITY, Models, Economic, Social protection, indirect cost, 030211 gastroenterology & hepatology, Female, Uridine Monophosphate, RIBAVIRIN, Adult, INTERFERON, VIRUS-INFECTION, sofosbuvir, public economic, 03 medical and health sciences, medicine, Humans, Fluorenes, business.industry, fiscal, GENOTYPE 1 INFECTION, Hepatitis C, Chronic, medicine.disease, United Kingdom, Early Diagnosis, Economic evaluation, HEALTH-CARE, Benzimidazoles, business
وصف الملف: application/pdf
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::617b8fd0d17129a7dcf08a84bda04d4bTest
https://doi.org/10.1080/13696998.2017.1371032Test -
2
المؤلفون: Ibrahim Guney, M. Kemal Basarali, N. Yılmaz Selçuk, Huseyin Atalay, Lutfullah Altintepe, Sadık Büyükbaş
المساهمون: Selçuk Üniversitesi
مصطلحات موضوعية: Adult, Male, Adrenergic Antagonists, medicine.medical_specialty, medicine.drug_class, Aldosterone escape, Urology, Angiotensin-Converting Enzyme Inhibitors, Critical Care and Intensive Care Medicine, Transforming Growth Factor beta1, chemistry.chemical_compound, Mineralocorticoid receptor, Internal medicine, medicine, Humans, Prospective Studies, Mineralocorticoid Receptor Antagonists, Aldosterone, business.industry, Glomerulosclerosis, General Medicine, Middle Aged, medicine.disease, Fibrosis, Endocrinology, spironolactone, chemistry, Nephrology, Mineralocorticoid, Potassium-sparing diuretic, Disease Progression, Spironolactone, Kidney Failure, Chronic, Female, proteinuria, business, TGF-beta 1, chronic kidney disease, Kidney disease
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f756b9a76f3c135b834003813eb952b6Test
https://hdl.handle.net/20.500.12395/23284Test